Selected Start-Ups (11/2002)
Executive Summary
In Vivo briefly summarizes the technologies of these recently founded companies: Anacor Pharmaceuticals Inc., Auxeris Therapeutics Inc., Chimerix Inc., Ercole BioTech Inc., iThemba Pharmaceuticals (Pty) Ltd. and Trinity Biosystems Inc.
You may also be interested in...
Teva Looks To Novartis To Replace Departing Dethlefs
Teva’s commercial interests in North America will soon be under new leadership after the firm announced that Sven Dethlefs would leave the company in mid-November. The firm has looked to the branded sector for his replacement.
Hengrui, Affiliate Reistone In Apparent Dispute Over China Ivarmacitinib NDAs
The future fate of Jiangsu Hengrui’s new drug discovery and development subsidiary may provide some tips on what’s ahead for the Chinese biopharma sector.
NASH Accelerated Approval: US FDA Remains Confident In Pathway For Liver Disease
A two-day workshop on potential biomarkers in NASH provided a forum for US FDA officials to offer implicit reassurance to drug developers: the agency stands behind its guidance on Accelerated Approval for the liver disease, despite the rejection of the first application seeking to use that approach.